Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Clinical trial NCT01638546 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01638546
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-27
- Primary completion
- 2017-01-09
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.